S100A4+ macrophage-specific Smad4 deletion enhances colitis-associated tumorigenesis by promoting macrophage lipid metabolism-dependent M2 polarization, thereby revealing Smad4 in S1000A4+ macrophages as a potential prognostic marker for CRC patients. This evidence concerns the gene SMAD4 and colorectal carcinoma.